ArticleAnnals of surgical oncology2022

Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels.

Ankit Dhiman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.